由于COVID-19和通货膨胀,马来西亚的保险费用猛增56%,促使监管者要求进行定价改革。 Malaysian insurance costs surged 56% due to COVID-19 and inflation, prompting regulators to demand pricing reforms.

由于COVID-19大流行和医疗通货膨胀等因素,马来西亚保险业和Takaful工业的医疗报销费用从2021年到2023年增长了56%。 The Malaysian insurance and takaful industry saw a 56% rise in medical claims costs from 2021 to 2023, driven by factors like the COVID-19 pandemic and medical inflation. 马来西亚金融监管机构马来西亚中央银行正在敦促保险公司重新评估其定价战略,以防止不公平的保险费上涨。 Bank Negara Malaysia, the country's financial regulator, is urging insurance companies to reassess their pricing strategies to prevent unfair premium hikes. BNM强调,需要协调改革,以控制保健费用,确保持续获得保险和 takaful覆盖。 BNM stresses the need for coordinated reforms to control healthcare costs and ensure continued access to insurance and takaful coverage.